|
|
|
Anesthesia: A Comprehensive Review
|
(Buch) |
Dieser Artikel gilt, aufgrund seiner Grösse, beim Versand als 3 Artikel!
| Inhalt: |
Prepare for success on high-stakes exams with Anesthesia: A Comprehensive Review, 7th Edition! With complete, up-to-date coverage of everything from basic science through current clinical practice, this fully revised review tool contains more than 1,000 board review-style questions in a multiple choice format. You’ll reinforce your current knowledge, identify areas that require more study, and improve your long-term retention of the material-all while preparing for certification and re-certification examinations as well as clinical practice.- Contains more than 1,000 fully updated multiple choice questions (100+ new to this edition) with answers and supporting explanations
- Mirrors the ABA written exam content and format, with challenging board review questions and answers covering the latest discoveries and techniques in physics, biochemistry, and anesthesia equipment; the newest drugs and drug categories; and the most recent information on all anesthesia subspecialties
- Features new questions on technology and devices, geriatric patients, demographic data, blood banking, transfusion, anticoagulants and anticoagulant reversal drugs, as well as new questions comparing medications/drugs with similar pharmacodynamic effects
- Offers discussions after each question, along with corresponding page references to major anesthesia texts so it’s easy to find more information on any subject
- Allows you to test interactively online with a scoreboard and notes field, and features a new, online-only chapter featuring additional open-ended questions
- An eBook version is included with purchase. The eBook allows you to access all of the text, figures, and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date
|
|
Auf Bestellung (Lieferzeit unbekannt)
Newsfeed | 
Facebook | 
Twitter
